Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 7,390 | 5,550 | 8,429 | 7,141 | 10,365 |
| Operating Income | -7,390 | -5,550 | -8,429 | -7,141 | -10,365 |
| Other Income | 157 | -490 | 141 | 1,325 | 1,035 |
| Pre-tax Income | -7,233 | -6,040 | -8,288 | -5,816 | -9,330 |
| Net Income Continuous | -7,233 | -6,040 | -8,288 | -5,816 | -9,330 |
| Net Income | $-7,233 | $-6,040 | $-8,288 | $-5,816 | $-9,330 |
| EPS Basic Total Ops | -0.09 | -0.07 | -0.10 | -0.06 | -0.13 |
| EPS Basic Continuous Ops | -0.09 | -0.07 | -0.10 | -0.07 | -0.13 |
| EPS Diluted Total Ops | -0.09 | -0.07 | -0.10 | -0.06 | -0.13 |
| EPS Diluted Continuous Ops | -0.09 | -0.07 | -0.10 | -0.07 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.07 | -0.07 | -0.07 | -0.13 |
| EBITDA(a) | $-7,371 | $-5,531 | $-8,412 | $-7,107 | $-10,217 |